HCK

Hematopoietic cell kinase
Identifiers
Symbol	?
NCBI gene	3055
HGNC	4858
OMIM	142420
RefSeq	NM_002110
UniProt	P08631
Other data
EC number	2.7.10.2
Search for Structures Swiss-model Domains InterPro

Hematopoietic cell kinase (HCK) is a member of the Src family of non-receptor tyrosine kinases. It is primarily expressed in hematopoietic cells, such as monocytes, macrophages, and neutrophils. HCK plays a crucial role in the signaling pathways that regulate the immune response, cell growth, and differentiation.

Structure

HCK is composed of several domains that are characteristic of Src family kinases. These include:

• An N-terminal SH3 domain, which is involved in protein-protein interactions.
• An SH2 domain, which binds to phosphorylated tyrosine residues on other proteins.
• A kinase domain, which is responsible for its enzymatic activity.
• A C-terminal regulatory region that contains a tyrosine residue whose phosphorylation state regulates the kinase activity.

Function

HCK is involved in various cellular processes, including:

• Signal transduction: HCK transmits signals from cell surface receptors to intracellular targets, influencing cell behavior.
• Phagocytosis: HCK is involved in the engulfment and digestion of pathogens by immune cells.
• Cytokine production: HCK modulates the production of cytokines, which are critical for immune responses.

Regulation

HCK activity is tightly regulated by phosphorylation. The phosphorylation of a specific tyrosine residue in the C-terminal tail (Tyr527 in humans) keeps the kinase in an inactive conformation. Dephosphorylation of this residue or phosphorylation of another tyrosine residue in the activation loop (Tyr416) activates the kinase.

Clinical Significance

Aberrant HCK activity has been implicated in various diseases, including:

• Chronic myeloid leukemia (CML): Overexpression or constitutive activation of HCK can contribute to the pathogenesis of CML.
• Inflammatory diseases: Dysregulation of HCK activity can lead to excessive inflammatory responses.

Research

HCK is a target for drug development, particularly in the context of cancer and inflammatory diseases. Inhibitors of HCK are being investigated for their potential therapeutic benefits.

Also see

• Src family kinases
• Tyrosine kinase
• Signal transduction
• Hematopoiesis